- Home
- CXDO vs TLSA Comparison
CXDO vs TLSA Comparison
Compare CXDO & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- TLSA
- Stock Information
- Founded
- CXDO 1995
- TLSA 2013
- Country
- CXDO United States
- TLSA United Kingdom
- Employees
- CXDO N/A
- TLSA N/A
- Industry
- CXDO Telecommunications Equipment
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- CXDO Telecommunications
- TLSA Health Care
- Exchange
- CXDO Nasdaq
- TLSA Nasdaq
- Market Cap
- CXDO 171.0M
- TLSA 187.0M
- IPO Year
- CXDO 1998
- TLSA 2000
- Fundamental
- Price
- CXDO $5.57
- TLSA $2.50
- Analyst Decision
- CXDO Strong Buy
- TLSA
- Analyst Count
- CXDO 3
- TLSA 0
- Target Price
- CXDO $8.50
- TLSA N/A
- AVG Volume (30 Days)
- CXDO 130.6K
- TLSA 331.0K
- Earning Date
- CXDO 08-05-2025
- TLSA 08-05-2025
- Dividend Yield
- CXDO N/A
- TLSA N/A
- EPS Growth
- CXDO 51.44
- TLSA N/A
- EPS
- CXDO 0.09
- TLSA N/A
- Revenue
- CXDO $62,609,000.00
- TLSA N/A
- Revenue This Year
- CXDO $13.10
- TLSA N/A
- Revenue Next Year
- CXDO $10.97
- TLSA N/A
- P/E Ratio
- CXDO $62.73
- TLSA N/A
- Revenue Growth
- CXDO 13.85
- TLSA N/A
- 52 Week Low
- CXDO $3.62
- TLSA $0.63
- 52 Week High
- CXDO $7.34
- TLSA $2.59
- Technical
- Relative Strength Index (RSI)
- CXDO 41.81
- TLSA 85.83
- Support Level
- CXDO $5.55
- TLSA $1.62
- Resistance Level
- CXDO $5.99
- TLSA $1.89
- Average True Range (ATR)
- CXDO 0.20
- TLSA 0.15
- MACD
- CXDO -0.05
- TLSA 0.09
- Stochastic Oscillator
- CXDO 5.49
- TLSA 92.25
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.